These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 6801641

  • 1. [Use of lithium carbonate in the therapy of diffuse toxic goiter].
    Pimenov LT.
    Probl Endokrinol (Mosk); 1982; 28(1):26-32. PubMed ID: 6801641
    [Abstract] [Full Text] [Related]

  • 2. [Experience using lithium carbonate in the complex treatment of diffuse toxic goiter].
    Petrov NM.
    Ter Arkh; 1985; 57(12):32-6. PubMed ID: 3937256
    [Abstract] [Full Text] [Related]

  • 3. Treatment of thyrotoxicosis with lithium carbonate.
    Lazarus JH, Richards AR, Addison GM, Owen GM.
    Lancet; 1974 Nov 16; 2(7890):1160-3. PubMed ID: 4139588
    [No Abstract] [Full Text] [Related]

  • 4. [Changes in the hormone profile, central hemodynamics and tissue blood flow in patients with thyrotoxic goiter during treatment with lithium carbonate].
    Petrov IM.
    Med Radiol (Mosk); 1986 Apr 16; 31(4):13-5. PubMed ID: 3083189
    [Abstract] [Full Text] [Related]

  • 5. [Calcitonin and parathyroid hormone secretion and calcium metabolism in patients with diffuse toxic goiter during treatment with lithium carbonate].
    Petrov NM.
    Probl Endokrinol (Mosk); 1984 Apr 16; 30(1):22-6. PubMed ID: 6424108
    [Abstract] [Full Text] [Related]

  • 6. [Dynamics of the hormone profile and cardiovascular changes in toxic goiter as affected by lithium carbonate].
    Petrov NM, Petrova NS.
    Probl Endokrinol (Mosk); 1983 Apr 16; 29(6):23-7. PubMed ID: 6318217
    [Abstract] [Full Text] [Related]

  • 7. Lithium carbonate therapy for induction of euthyroid state in thyrotoxicosis. A preliminary study.
    Bhansali A, Nalini K, Dash RJ.
    J Assoc Physicians India; 1990 Dec 16; 38(12):911-3. PubMed ID: 2128939
    [Abstract] [Full Text] [Related]

  • 8. Effect of short-term lithium carbonate administration in hyperthyroidism, with or without associated ophthalmopathy.
    Bistriceanu M, Roşca TR, Mocanu I, Bistriceanu I, Voinea F.
    Endocrinologie; 1986 Dec 16; 24(2):109-13. PubMed ID: 3090679
    [Abstract] [Full Text] [Related]

  • 9. Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3.
    Burman KD, Dimond RC, Earll JM, Wright FD, Wartofsky L.
    J Clin Endocrinol Metab; 1976 Sep 16; 43(3):606-13. PubMed ID: 989049
    [Abstract] [Full Text] [Related]

  • 10. [Lithium carbonate in the treatment of patients with diffuse toxic goiter].
    Petrov NM.
    Vrach Delo; 1986 Jun 16; (6):64-6. PubMed ID: 3092467
    [No Abstract] [Full Text] [Related]

  • 11. [Short-term use of lithium carbonate in the treatment of thyrotoxicosis].
    Jonderko G, Marcisz C.
    Z Gesamte Inn Med; 1979 Aug 01; 34(15):408-11. PubMed ID: 93353
    [Abstract] [Full Text] [Related]

  • 12. [Lithium in the treatment of thyrotoxicosis (clinico-biological aspects)].
    Petrov NM, Semenov VV.
    Probl Endokrinol (Mosk); 1986 Aug 01; 32(2):83-6. PubMed ID: 2424005
    [No Abstract] [Full Text] [Related]

  • 13. The use of lithium carbonate in the preparation for definitive therapy in hyperthyroid patients.
    Akin F, Yaylali GF, Bastemir M.
    Med Princ Pract; 2008 Aug 01; 17(2):167-70. PubMed ID: 18287805
    [Abstract] [Full Text] [Related]

  • 14. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E, Gardini E, Minelli R, Bianconi L, Salvi M, Gavaruzzi G, Braverman LE.
    J Clin Endocrinol Metab; 1993 Apr 01; 76(4):928-32. PubMed ID: 7682562
    [Abstract] [Full Text] [Related]

  • 15. [Criteria of the test of suppression of thyroid uptake of I131 by triiodothyronine].
    Aliiakparova ASh.
    Probl Endokrinol (Mosk); 1975 Apr 01; 21(4):13-7. PubMed ID: 1243828
    [Abstract] [Full Text] [Related]

  • 16. [Lithium carbonate in the treatment of diffuse toxic goiter].
    Leshchinskiĭ LA, Trusov VV, Pimenov LT.
    Ter Arkh; 1982 Apr 01; 54(2):113-8. PubMed ID: 6803379
    [No Abstract] [Full Text] [Related]

  • 17. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F, Giovannetti C, Fessehatsion R, Tanda ML, Campomori A, Compri E, Rossi G, Ceccarelli C, Vitti P, Pinchera A, Bartalena L, Martino E.
    J Clin Endocrinol Metab; 2010 Jan 01; 95(1):201-8. PubMed ID: 19906789
    [Abstract] [Full Text] [Related]

  • 18. [The use of lithium carbonate in treating patients with diffuse toxic goiter].
    Balabolkin MI, Petunina NA, Tsaguriia KG.
    Klin Med (Mosk); 1990 Oct 01; 68(10):68-9. PubMed ID: 1706446
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism.
    Bogazzi F, Bartalena L, Brogioni S, Scarcello G, Burelli A, Campomori A, Manetti L, Rossi G, Pinchera A, Martino E.
    J Clin Endocrinol Metab; 1999 Feb 01; 84(2):499-503. PubMed ID: 10022407
    [Abstract] [Full Text] [Related]

  • 20. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
    Bogazzi F, Bartalena L, Campomori A, Brogioni S, Traino C, De Martino F, Rossi G, Lippi F, Pinchera A, Martino E.
    J Clin Endocrinol Metab; 2002 Oct 01; 87(10):4490-5. PubMed ID: 12364424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.